(Q24236595)

5

0 references

Francesca Sperati

7

0 references

Irene Terrenato

6

0 references

Elie A Akl

1

0 references

Victor E D Yosuico

4

object named as

Victor E D Yosuico

0 references

Srinivasa Rao Vasireddi

2

object named as

Srinivasa Rao Vasireddi

0 references

Sameer Gunukula

Cochrane Database of Systematic Reviews

3

object named as

Sameer Gunukula

0 references

publication date

15 June 2011

0 references

published in

0 references

cites work

A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006466.PUB3

The first international urokinase/warfarin trial in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006466.PUB3

Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006466.PUB3

Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate: Final Report of VA cooperative study # 75

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006466.PUB3

Intensive combination chemotherapy, concurrent chest irradiation, and warfarin for the treatment of limited-disease small-cell lung cancer: a Cancer and Leukemia Group B pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006466.PUB3

Phase II trial of coumarin and cimetidine in advanced renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006466.PUB3

Warfarin inhibition of metastasis: the role of anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006466.PUB3

Coumarin (1,2-benzopyrone) for the treatment of prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006466.PUB3

Activity of coumarin and cimetidine in metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006466.PUB3

Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006466.PUB3

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006466.PUB3

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006466.PUB3

From Trousseau to targeted therapy: new insights and innovations in thrombosis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006466.PUB3

Increased incidence of neoplasia of the digestive tract in men with persistent activation of the coagulant pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006466.PUB3

Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006466.PUB3

Adjuvant therapy of cancer via the cellular immune mechanism or fibrin by induced fibrinolysis and oral anticoagulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006466.PUB3

7 January 2021

No effect of an antiaggregant treatment with aspirin in small cell lung cancer treated with CCAVP16 chemotherapy. Results from a randomized clinical trial of 303 patients. The "Petites Cellules" Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006466.PUB3

7 January 2021

Treatment of advanced malignant melanoma with coumarin and cimetidine: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006466.PUB3

7 January 2021

Treatment with coumarin to prevent or delay recurrence of malignant melanoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006466.PUB3

7 January 2021

Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006466.PUB3

7 January 2021

Hemostasis and malignancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006466.PUB3

7 January 2021

Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006466.PUB3

7 January 2021

Randomised study using IFN-alpha versus IFN-alpha plus coumarin and cimetidine for treatment of advanced renal cell cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006466.PUB3

7 January 2021

Cancer incidence and mortality in patients with heart disease. Effect of oral anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006466.PUB3

7 January 2021

Warfarin for small-cell lung cancer: why not?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006466.PUB3

7 January 2021

Warfarin and small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006466.PUB3

7 January 2021

Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a Cancer and Leukemia Group B study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006466.PUB3

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD006466.PUB3

1 reference

7 January 2021